目的 探讨术后恢复综合方案联合系统呼吸训练应用于肺结节手术患者的效果。方法 选取解放军联勤保障部队第九一〇医院2019年6月—2022年8月期间收治的175例肺结节手术患者,按照随机数字表法分为对照组（87例,给予术后恢复综合方案干预）和观察组（88例,在对照组的基础上予以系统呼吸训练）。观察并比较两组患者临床指标、呼吸功能、肺功能、并发症发生率。结果 观察组患者首次排气时间、首次排便时间、首次离床时间、引流管留置时间及住院时间均短于对照组（P<0.05）,干预后的呼吸频率和Borg疲劳量表评分均低于对照组（P<0.05）,干预后的用力肺活量（FVC）、第1秒用力呼吸容积（FEV₁）、FEV₁/FVC均高于对照组（P<0.05）,并发症发生率低于对照组（P<0.05）。结论 术后恢复综合方案联合系统呼吸训练能够改善肺结节手术患者肺功能和呼吸功能,降低并发症发生率,缩短术后康复时间。

Objective To explore the effect of a comprehensive postoperative recovery plan combined with systemic respiratory training in patients undergoing pulmonary nodule surgery. Methods According to the random number table method, 175 patients who underwent pulmonary nodule surgery in the 910 Hospital of Joint Logistics Support Force from June 2019 to August 2022 were divided into two groups： the control group of 87 patients received comprehensive postoperative recovery intervention, and the observation group of 88 patients received systemic respiratory training on the basis of the control group. Clinical indicators, respiratory function, pulmonary function, and incidence of complications were observed and compared between the two groups of patients. Results After the intervention, the observation group had shorter first exhaust time, first defecation time, out-of-bed time, drainage tube retention time, and hospitalization time than the control group （P<0.05）. The respiratory frequency and the Borg fatigue scale score after intervention in the observation group were lower than those in the control group （P<0.05）. The forced vital capacity （FVC）, forced expiratory volume in 1 s （FEV₁）, and FEV₁/FVC of the observation group after intervention were all higher than those of the control group （P<0.05）. The incidence of complications in the observation group was lower than that in the control group （P<0.05）. Conclusion The comprehensive postoperative recovery plan combined with systemic respiratory training can improve lung function and respiratory function, reduce the incidence of complications, and shorten postoperative recovery time in patients undergoing pulmonary nodule surgery.